Frontotemporal Dementia

Nicole Salfi, M.D., Christopher Morrow, M.D., Tamela McClam, M.D., Chiadi Onyike‎, M.D.

DEFINITION

  • Frontotemporal dementia (FTD) encompasses a group of neurodegenerative diseases primarily affecting the frontal and temporal lobes, resulting in progressive impairments in personality, behavior, executive functioning and language. FTD includes three main clinical syndromes:
    • Behavior variant FTD (bvFTD)
      • The most common variant, it is characterized by a progressive deterioration of conduct, judgement, and personality, associated with radiological evidence of frontal and/or anterior temporal atrophy or hypometabolism.[1]
    • Primary progressive aphasias (PPA)/language variants
      • Non-fluent/agrammatic variant (nfvPPA)
        • Presents with labored and agrammatic speech alongside impaired sentence comprehension, with sparing of word and object knowledge, in association with radiological evidence of left posterior fronto-insular atrophy or hypometabolism[2]
      • Semantic variant (svPPA)
        • Manifests as fluent but vacuous speech, featuring dysnomia and agnosia for words and objects, in association with radiological evidence of focal anterior temporal atrophy or hypometabolism[2]
  • Eventually all phenotypes converge on a global dementia state, in which severe disability is observed in every cognitive and functional domain.[3]
  • Frontotemporal lobar degeneration (FTLD) refers to the histopathological state that underlies the clinical syndromes.
  • Cognitive impairment due to frontotemporal dementia is classified under the neurocognitive disorders (NCDs) section of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).[4]

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 2, 2025